The Harvard Gazette

buprenorphine

Page 1 of 1

Raina McMahan and Dr. Sarah Wakeman at the confernce

Stigma of opioids a hurdle to solving crisis

Conference finds that it keeps users from seeking help, taints views of medical professionals

Health|

DateOctober 11, 2019October 11, 2019

Proven opioid treatment faces roadblocks

Buprenorphine difficult to access, especially among patients with Medicaid coverage

Health|

DateJune 3, 2019May 31, 2019

“Our results suggest that abstinence-focused, 12-step residential treatment may be able to help young adults recover from opioid addiction through a different pathway than the more typical outpatient approach incorporating buprenorphine/naloxone treatment,” said John Kelly, the Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine at Harvard Medical School.

Improving the odds of beating opioids

Residential treatment rather than standard outpatient care may be better for the opioid-dependent

Health|

DateNovember 21, 2014